Showing results (1321-1330 of 10,079) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|August 24, 2004
Retracted: Effects of Vitamin K2 on OsteoporosisJun Iwamoto, Tsuyoshi Takeda, Yoshihiro SatoCurrent Pharmaceutical Design|August 24, 2004
Possible therapeutic targets in cardiac myocyte apoptosisP Andreka, Z Nadhazi, G Muzes, et al.Current Pharmaceutical Design|August 24, 2004
Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns?Pal Pacher, Valeria KecskemetiCurrent Pharmaceutical Design|August 24, 2004
Acute actions of natriuretic peptides in coronary vasculature and ischaemic myocardiumYohann Rautureau, Gary F BaxterCurrent Pharmaceutical Design|July 30, 2004
Arterial hyperoxia in severe head injury: a useful or harmful option?O L Alves, W P Daugherty, M RiosCurrent Pharmaceutical Design|July 30, 2004
Drug therapy in schizophreniaJ Ananth, S Parameswaran, B HaraCurrent Pharmaceutical Design|July 30, 2004
Side effects of atypical antipsychotic drugsJ Ananth, S Parameswaran, S GunatilakeCurrent Pharmaceutical Design|July 30, 2004
The use of antiparkinsonian agents in the management of drug-induced extrapyramidal symptomsK Burgyone, K Aduri, J Ananth, et al.Current Pharmaceutical Design|July 30, 2004
Treatment considerations in the forensic patient with schizophreniaDavid C Stone, David O NizCurrent Pharmaceutical Design|July 30, 2004
Cognitive therapy for schizophrenia: treatment and disseminationL Marcinko, M ReadPageof 1,008